Entero Healthcare Solutions IPO 2024: Dates, Price, Financial Analysis
Learn about Entero Healthcare Solutions IPO opening from February 9 to February 13, 2024, with a price range of Rs. 1195 to Rs. 1258 per share. Discover the total issue size, allocation details, financial performance, promoters, lead managers, valuation metrics (P/E ratio), strengths, weaknesses, and Grey Market Premium (GMP). Make an informed investment decision in the healthcare sector with insights into Entero's distribution platform, growth potential, and associated risks
sonu
Share this Post to earn Money ( Upto ₹100 per 1000 Views )
Entero Healthcare Solutions
Entero Healthcare Solutions, founded in 2018, has emerged as a leading healthcare product distributor, connecting manufacturers, hospitals, and pharmacies across India. With an extensive network of 73 warehouses in 37 cities, covering 495 districts and partnering with over 1900 manufacturers, Entero offers a vast selection of over 64500 SKUs, serving the healthcare needs efficiently. Collaborations with 3400 hospitals and 81400+ retail pharmacies strengthen its network.
The Entero Healthcare Solutions IPO is set to open from February 9 to February 13, 2024, with a price range of Rs. 1195 to Rs. 1258 per share. The total issue size is Rs. 1600.00 crore, with allocations for institutional, retail, and other investors.
Financially, Entero has shown improvements in various metrics over previous years. Despite a negative PAT in the latest period, its total revenue and net worth have increased. The company plans to utilize the net proceeds for debt repayment, working capital, inorganic growth initiatives, and general corporate purposes.
The promoters of Entero Healthcare Solutions IPO include Prabhat Agrawal, Prem Sethi, and OrbiMed Asia III Mauritius Limited. ICICI Securities Limited, Dam Capital Advisors Ltd, Jefferies India Private Limited, JM Financial Limited, and SBI Capital Markets Limited are the lead managers.
The IPO's valuation, with a P/E ratio ranging from 405.80x to 228.72x, seems neutral compared to the industry average of 216.07x. Despite not paying dividends in the past, the company's strengths lie in its fast growth, strong supply chain solutions, and innovative technology.
However, there are weaknesses such as exposure to financial loss, potential market price changes, and limited exposure due to primarily domestic revenue generation. The IPO's Grey Market Premium (GMP) stands at Rs. 125.
In conclusion, Entero Healthcare Solutions IPO presents a promising opportunity with its strong distribution platform and growth potential in the healthcare sector. Investors should consider consulting their financial advisors before making any decisions.
